DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT

This adverse event was reported 2207 times

These drugs are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT:

# Drug Count
0 RITUXIMAB 1513
1 CYCLOPHOSPHAMIDE 1305
2 CYCLOPHOSPHAMIDE FOR INJECTION 1305
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1305
4 DOXORUBICIN 1181
5 PREDNISONE 1003
6 DEXAMETHASONE 541
7 DEXAMETHASONE 1.5 MG 541
8 CYTARABINE 502
9 ETOPOSIDE 483
See all common drugs associated with DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT

DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 POLATUZUMAB VEDOTIN 391 0.0383
1 GLOFITAMAB 78 0.0288
2 MOSUNETUZUMAB 28 0.0253
3 BENDAMUSTINE HCL 302 0.0193
4 CARMUSTINE 77 0.0163
5 LONCASTUXIMAB TESIRINE 6 0.0146
6 EPCORITAMAB-BYSP 19 0.0142
7 IFOSFAMIDE FOR INJECTION 294 0.0137
8 DOXORUBICIN 1181 0.0131
9 ETOPOSIDE PHOSPHATE 21 0.0128
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT